MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT)
Finance & Acquisitions: Intercept
Parents
Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT)
Children
2023: After 2 FDA rejections and restructuring drive, Intercept sells itself to Italy's Alfasigma
2023: Alfasigma Buys Beleaguered Intercept Pharmaceuticals in $800M Cash Deal
2023: Intercept Pharmaceuticals: Alfasigma Pays Premium For M&A Deal That Suits All Parties
Intercept Pharmaceutical Stock Quote: ICPT Stock News, Quotes, Analysis
Intercept Pharmaceuticals
Revenue: $250.2 million USD (2019)
Jumps
*Key People: Intercept
Organization & Developments: Intercept